Knockdown of lncRNA AGPG disrupts the formation of the PURα/E2F1 complex, releasing E2F1 from the PURα/E2F1 complex, leading to the activation of the E2F1 signaling pathway, which promotes BC cell cycle progression and endocrine resistance (Yu et al. 2023). Here, PURA is linked to breast cancer.